Candid Therapeutics
Clinical trials sponsored by Candid Therapeutics, explained in plain language.
-
New drug cizutamig tested for thyroid eye disease – early trial seeks safety data
Disease control Recruiting nowThis early-stage study tests a new drug called cizutamig in 38 adults with active, moderate-to-severe thyroid eye disease (TED). The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that the drug might help control the di…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New lupus drug cizutamig enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug, cizutamig, in 47 adults with systemic lupus erythematosus (SLE) who haven't responded well to standard treatments. The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that the dru…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New drug trial offers hope for muscle weakness sufferers
Disease control Recruiting nowThis study is testing a new medicine called cizutamig in people with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. The main goal is to check if the drug is safe and how the body processes it. About 44 adults with moderate to severe symptoms who hav…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:56 UTC